Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the rest. By Simar Bajaj Screening can be a powerful weapon against cancer, ...

Tislelizumab and sitravatinib as adjuvant therapy for hepatocellular carcinoma patients at high risk of recurrence following surgical resection: A multi-center, non-randomized, open-label phase 2 ...